tiprankstipranks
Kezar Life Sciences Inc (KZR)
NASDAQ:KZR

Kezar Life Sciences (KZR) Financial Statements

434 Followers

Kezar Life Sciences Financial Overview

Kezar Life Sciences's market cap is currently ―. The company's EPS TTM is $-1.394; its P/E ratio is -0.45; Kezar Life Sciences is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue--$ 7.00M--
Gross Profit--$ 7.00M--
EBIT$ -21.26M$ -31.86M$ -22.71M$ -23.92M$ -21.83M
EBITDA$ -21.00M$ -31.58M$ -24.14M$ -25.43M$ -23.22M
Net Income Common Stockholders$ -21.66M$ -32.26M$ -23.10M$ -24.31M$ -22.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 179.80M$ 201.37M$ 218.21M$ 236.59M$ 257.67M
Total Assets$ 199.13M$ 221.24M$ 249.33M$ 263.38M$ 284.18M
Total Debt$ 18.29M$ 18.93M$ 19.55M$ 20.15M$ 20.72M
Net Debt$ -161.51M$ -182.44M$ -198.65M$ -216.44M$ -236.95M
Total Liabilities$ 30.01M$ 33.66M$ 33.33M$ 31.10M$ 31.69M
Stockholders Equity$ 169.14M$ 187.57M$ 215.99M$ 232.28M$ 252.49M
Cash Flow-
Free Cash Flow$ -22.86M$ -18.98M$ -20.34M$ -22.98M$ -21.16M
Operating Cash Flow$ -22.86M$ -18.98M$ -20.20M$ -21.60M$ -20.86M
Investing Cash Flow$ 20.41M$ 27.88M$ 18.57M$ 13.20M$ 16.39M
Financing Cash Flow-$ 59.00K$ 43.00K$ 382.00K$ 154.00K
Currency in USD

Kezar Life Sciences Earnings and Revenue History

Kezar Life Sciences Debt to Assets

Kezar Life Sciences Cash Flow

Kezar Life Sciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis